Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2Robert Stuver,Laure Michaud,Carla Casulo,Ranjana H. Advani,Elizabeth L. Budde,Paul M. Barr,Connie Lee Batlevi,Philip C. Caron,Louis S. Constine,Savita Dandapani,Pamela Drullinsky,Jonathan W. Friedberg,Clare Grieve,Audrey Hamilton,Paul A. Hamlin,Richard Hoppe,Steven M. Horwitz,Niloufer Khan,Matthew J. Matasar,Ariela Noy, M. Lia Palomba, Heiko Schoder, David J. Straus, Shreya Vemuri, Joachim Yahalom, Joanna C. Yang, Anas Younes, Andrew D. Zelenetz, Craig H. Moskowitz, Anita Kumar, Alison J. MoskowitzBlood（2022）引用 1|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
